Contraception for women with diabetes: an update (Q37527867)

20 August 2017

1 reference

title

Contraception for women with diabetes: an update (English)

1 reference

20 August 2017

1 reference

S O Skouby

1

1 reference

20 August 2017

L Mølsted-Pedersen

series ordinal

2

1 reference

20 August 2017

K R Petersen

series ordinal

3

1 reference

20 August 2017

publication date

1 June 1991

1 reference

Bailliere's clinical obstetrics and gynaecology

20 August 2017

published in

1 reference

20 August 2017

volume

5

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

493-503

1 reference

Comparison of the mechanisms underlying carbohydrate intolerance in subclinical diabetic women during pregnancy and during post-partum oral contraceptive steroid treatment.

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Insulin receptors during the menstrual cycle in normal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Clinical and hormonal characteristics in women with anovulation and insulin-treated diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Potency and pharmacokinetics of gestagens

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Low-dose oral contraceptives and carbohydrate metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Intrauterine contraceptive devices in diabetic women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Effects of oral contraceptive agents on carbohydrate metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Fibrinolytic activity of the endometrium in diabetic women using Cu-IUDs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

1 reference

7 January 2021

Clinical pharmacokinetics of oral contraceptive steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Oral contraception in diabetic women. Diabetes control, serum and high density lipoprotein lipids during low-dose progestogen, combined oestrogen/progestogen and non-hormonal contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

New progestogens in oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Oral contraception with a nonalkylated estrogen component. Effects on lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Consequences of intrauterine contraception in diabetic women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Triphasic oral contraception: metabolic effects in normal women and those with previous gestational diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Hormonal contraception in diabetic women: acceptability and influence on diabetes control and ovarian function of a nonalkylated estrogen/progestogen compound.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Oral contraceptives in diabetic women: metabolic effects of four compounds with different estrogen/progestogen profiles.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

The effect of estrogens on carbohydrate metabolism: glucose, insulin, and growth hormone studies on one hundred and seventy-one women ingesting Premarin, mestranol, and ethinyl estradiol for six months.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Carbohydrate metabolism prospectively studied in women using a low-estrogen oral contraceptive for six months

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Contraception for the insulin-dependent diabetic woman: the view from one clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Glucose Tolerance in Gestational Diabetic Women during and after Treatment with a Combination-Type Oral Contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Efficacy of different contraceptive methods

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

The risk of pelvic inflammatory disease in women using intrauterine contraceptive devices as compared to non-users

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Intrauterine contraception in diabetic women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Oral contraceptives and diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

Evidence that multiple risk factors for coronary artery disease exist in persons with abnormal glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980109-9

7 January 2021

10.1016/S0950-3552(05)80109-9

Identifiers

DOI

1 reference

20 August 2017

1 reference